Showing results (11-20 of 53) with videos related to

Sort By:
Pageof 6
Cancers|June 26, 2026
Neoadjuvant Therapy and the Evolving Management of Resectable Advanced MelanomaNikolaos Papadopoulos, Michele Del Vecchio, Andrea Spagnoletti, et al.
Cancer Chemotherapy and Pharmacology|October 1, 2008
Multi-center phase II trial of chemo-radiotherapy with 5-fluorouracil, leucovorin and oxaliplatin in locally advanced esophageal cancerVanna Chiarion-Sileni, Roberto Innocente, Raffaele Cavina, et al.
Cancers|June 26, 2026
Adjuvant Approaches in Fully Resected Stage III and IV Cutaneous Melanoma: Where Are We Now?Luisa Piccin, Valentina Guarneri, Michele Del Vecchio, et al.
Melanoma Research|September 18, 2018
Clonal heterogeneity of melanoma in a paradigmatic case study: future prospects for circulating melanoma cellsMaria Chiara Scaini, Jacopo Pigozzo, Marco Pizzi, et al.
Melanoma Research|November 27, 2014
Impact of BRAF mutation and BRAF inhibition on melanoma brain metastasesTulasi Gummadi, Ben Y Zhang, Sara Valpione, et al.
Cancers|April 16, 2020
TERT Promoter Mutations Differently Correlate with the Clinical Outcome of MAPK Inhibitor-Treated Melanoma PatientsPaola Del Bianco, Camilla Stagni, Silvia Giunco, et al.
Journal of Experimental & Clinical Cancer Research : CR|May 5, 2021
The immune cell landscape of metastatic uveal melanoma correlates with overall survivalAnna Tosi, Rocco Cappellesso, Angelo Paolo Dei Tos, et al.
Frontiers in Pharmacology|April 15, 2025
Anti-CTLA-and anti-PD-1 immune checkpoint inhibitor antibodies impair human sperm motility in-vitroIlaria Cosci, Luca De Toni, Paolo Del Fiore, et al.
Plos One|March 18, 2015
Development and external validation of a prognostic nomogram for metastatic uveal melanomaSara Valpione, Justin C Moser, Raffaele Parrozzani, et al.
Cancers|September 26, 2018
Prognostic Factors in Merkel Cell Carcinoma: A Retrospective Single-Center Study in 90 PatientsMarco Rastrelli, Beatrice Ferrazzi, Francesco Cavallin, et al.
Pageof 6